The 5 analysts offering 12-month price forecasts for BioTelemetry Inc have a median target of 58.00, with a high estimate of 80.00 and a low estimate of 52.00. The median estimate represents a +24.28% increase from the last price of 46.67.
The current consensus among 6 polled investment analysts is to Buy stock in BioTelemetry Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.16
Reporting Date Aug 05
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.